Compare Albemarle Corp. (ALB) vs BioNano Genomics Inc (BNGO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Albemarle Corp. vs BioNano Genomics Inc — how do they compare? Albemarle Corp. trades at $129.3 (market cap $15.22B), while BioNano Genomics Inc trades at $1.14 (market cap $13.08M). The key difference: Albemarle Corp. is far larger — about 1163.6× BioNano Genomics Inc's market cap, and Albemarle Corp. pays a 1.26% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| ALB | BNGO | |
|---|---|---|
Market Cap | $15.22B | $13.08M |
Sector | Basic Materials | Health |
52-Week High | $215.62 | $4.92 |
52-Week Low | $67.30 | $1.09 |
Enterprise Value | $18.24B | $15.69M |
Dividend Yield | 1.26% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Albemarle Corp.
Albemarle is the world's largest lithium producer. Our outlook for robust lithium demand is predicated upon increased demand for electric vehicle batteries. Albemarle produces lithium from its salt brine deposits in Chile and the U.S. and its hard rock joint venture mines in Australia. Albemarle is also a global leader in the production of bromine, used in flame retardants. The company is also a major producer of oil refining catalysts.
Read more on ALB →About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →
